The Biden administration on Thursday asserted its authority to seize the patents of certain costly medications in a new push to slash high drug prices and promote more pharmaceutical competition.

The administration unveiled a framework outlining the factors federal agencies should consider in deciding whether to use a controversial policy, known as march-in rights, to break the patents of drugs that were developed with federal funds but are not widely accessible to the public. For the first time, officials can now factor in a medication’s price — a change that could have big implications for drugmakers depending on how the government uses the powers.

“When drug companies won’t sell taxpayer-funded drugs at reasonable prices, we will be prepared to allow other companies to provide those drugs for less,” White House National Economic Advisor Lael Brainard said during a call with reporters Wednesday.

  • lagomorphlecture@lemm.ee
    link
    fedilink
    arrow-up
    51
    arrow-down
    3
    ·
    11 months ago

    No, I feel the same way. It’s just that they’ve also utterly sucked in some areas too. Regardless, you know I’m hella voting for him because wtf else am I gonna do? There’s no choice in our political system so I’ll do what I need to.